Neuroprotection of Pioglitazone in Acute Ischemic Stroke

NCT02195791 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Diffculty in participant enrollment

Conditions

Stroke

Interventions

DRUG: Pioglitazone
DRUG: Placebo

Sponsor

Taipei Medical University Shuang Ho Hospital